COMPUGEN ($CGEN) posted quarterly earnings results for Q2 2026 on Monday, August 3rd. The company reported earnings of -$0.07 per share, beating estimates of -$0.08 by $0.01. The company also reported revenue of $2,600,000, beating estimates of $1,637,865 by $962,135.
You can see Quiver Quantitative's $CGEN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
COMPUGEN Insider Trading Activity
COMPUGEN insiders have traded $CGEN stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $CGEN stock by insiders over the last 6 months:
- ZURIT LEVINE (SVP, Business Development) has made 0 purchases and 8 sales selling 32,250 shares for an estimated $75,344.
- ERAN OPHIR (President and CEO) has made 0 purchases and 3 sales selling 15,625 shares for an estimated $42,934.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
COMPUGEN Hedge Fund Activity
We have seen 24 institutional investors add shares of COMPUGEN stock to their portfolio, and 25 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TWO SIGMA INVESTMENTS, LP added 217,644 shares (+71.6%) to their portfolio in Q1 2026, for an estimated $463,581
- STONEPINE CAPITAL MANAGEMENT, LLC removed 201,100 shares (-65.8%) from their portfolio in Q1 2026, for an estimated $428,343
- RENAISSANCE TECHNOLOGIES LLC added 176,088 shares (+12.1%) to their portfolio in Q1 2026, for an estimated $375,067
- MILLENNIUM MANAGEMENT LLC added 168,927 shares (+inf%) to their portfolio in Q1 2026, for an estimated $359,814
- SILVERARC CAPITAL MANAGEMENT, LLC removed 163,960 shares (-4.7%) from their portfolio in Q1 2026, for an estimated $349,234
- MARSHALL WACE, LLP added 138,176 shares (+130.0%) to their portfolio in Q1 2026, for an estimated $294,314
- ARAX ADVISORY PARTNERS added 131,800 shares (+inf%) to their portfolio in Q1 2026, for an estimated $280,734
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
COMPUGEN Price Targets
Multiple analysts have issued price targets for $CGEN recently. We have seen 2 analysts offer price targets for $CGEN in the last 6 months, with a median target of $5.5.
Here are some recent targets:
- An analyst from Leerink Partners set a target price of $5.0 on 05/21/2026
- Chad Messer from Lake Street set a target price of $6.0 on 04/07/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
